[The determination of the antiviral activity of the sorbent Evirkhip (in vitro studies)].
It was found that "Evirkhip" possesses a marked antiviral activity confirmed on a model of enteroviruses (coxsackie). The authors also studied the resistance to the drug in the chain: eukaryotic cell-viral particle-prokaryotic cell. The resistance decreased with the shift to right.
Boĭko
I I
II
Rudychenko
V F
VF
Volkova
V P
VP
Safro
H P
HP
Bondarenko
L I
LI
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000633:toxicity; D002478:Cells, Cultured / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D016061:Enterosorption; D029822:Enterovirus B, Human / Q000187:drug effects; D006801:Humans; D009930:Organic Chemicals; D010316:Particle Size; D017955:Poliovirus / Q000187:drug effects; D014709:Vero Cells / Q000187:drug effects
D000998:Antiviral Agents; D009930:Organic Chemicals; C079283:EVIRKHIP
Vyznachennia protyvirusnoï aktyvnosti sorbenta "Evirkhip" (doslidy in vitro).